Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasm
NCT02528526
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
69
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Neoplasms
Hepatocellular Cancer
Cholangiocarcinoma
Colorectal Neoplasms
Interventions
DRUG:
OXY111A
Sponsor
University of Zurich